FindMyKOL
Clinical trialNCT03968315Active, not recruitingInterventional

An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma

NCT03968315 is an interventional trial sponsored by M.D. Anderson Cancer Center. As of 21 Nov 2026, it is active and no longer recruiting. It studies Recurrent Malignant Thymoma and Thymoma. The registry lists an enrollment of 40 participants at 1 site in 1 country. The registry lists a start date of 8 Jun 2011 and a primary completion date of 30 Apr 2029.

SponsorM.D. Anderson Cancer CenterEnrollment40Recurrent Malignant ThymomaThymoma
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT03968315
FieldValue
Registry IDNCT03968315
StatusActive not recruiting
Study typeInterventional trial
Lead sponsorM.D. Anderson Cancer Center
Enrollment40
Registered sites1
Countries1
ConditionsRecurrent Malignant Thymoma and Thymoma
Start8 Jun 2011
Primary completion30 Apr 2029
Study completion30 Apr 2029
Last update posted18 Sept 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This trial studies the accuracy of a magnetic resonance imaging (MRI) scan in imaging the inside of the chest in patients with thymoma that is newly diagnosed or has come back. An MRI scan may be able to detect if and how far the tumor has spread more accurately than a standard computed tomography (CT) scan.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Texas, United States1 site
  • M D Anderson Cancer Center

    Houston

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 1 siteTX1FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT03968315

Each answer restates registry values shown on this page.

What is NCT03968315?

NCT03968315 is an interventional trial sponsored by M.D. Anderson Cancer Center. It studies Recurrent Malignant Thymoma and Thymoma.

Is NCT03968315 recruiting?

As of 21 Nov 2026, it is active and no longer recruiting.

Who leads NCT03968315?

The registry names Marcelo F Benveniste (principal investigator, M.D. Anderson Cancer Center) as the overall official.

Where does NCT03968315 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT03968315 expected to complete?

The registry lists a primary completion date of 30 Apr 2029 and a study completion date of 30 Apr 2029. The sponsor last updated the record on 18 Sept 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.